RADIATION THERAPY ONCOLOGY GROUP
RTOG 0529
A PHASE II EVALUATION OF DOSE-PAINTED IMRT IN COMBINATION WITH 5-FLUOROURACIL AND MITOMYCIN-C FOR REDUCTION OF ACUTE MORBIDITY IN CARCINOMA OF THE ANAL CANAL
RTOG 0529
A PHASE II EVALUATION OF DOSE-PAINTED IMRT IN COMBINATION WITH 5-FLUOROURACIL AND MITOMYCIN-C FOR REDUCTION OF ACUTE MORBIDITY IN CARCINOMA OF THE ANAL CANAL
Please note that institutions that
are credentialed to participate in other RTOG IMRT protocols
need not repeat the phantom experiment required for credentialing
on this protocol.
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire
-
RPC Phantom Dosimetry Test
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Structure Names
- Contouring Examples (PDF) updated 5/21/07
- Protocol Text (http://www.rtog.org)
Back to protocols
